Hydrogen Therapy Shows Promise Against Endometrial Cancer in Lab Study
- Authors
- Ye Yang, Ping Yin Liu, Wei Bao, Song Jun Chen, Fang Su Wu, Ping Ya Zhu
- Journal
- BMC Cancer
- Year
- 2020
- DOI
- 10.1186/s12885-019-6491-6
- Study Type
- Cell Culture
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Endometrial Cancer
- Body System
- Reproductive System
TL;DR
Hydrogen treatment can promote a specific type of cell death in endometrial cancer, potentially offering a new approach to therapy.
Key Finding
Hydrogen treatment activated a cellular death pathway in endometrial cancer cells and reduced tumor growth in mice, suggesting a potential mechanism for how hydrogen might help fight this type of cancer.
Summary
Researchers investigated whether hydrogen could slow the growth of endometrial cancer (cancer of the uterine lining) by triggering a specific type of cell death called pyroptosis. Using cancer cells in dishes and tumors grown in mice, they found that hydrogen treatment increased reactive oxygen species (unstable molecules that damage cells) and activated a chain of proteins that led cancer cells to die through pyroptosis, while the treatment reduced tumor size in mice.
Practical Takeaway
This early-stage research in cells and mice suggests hydrogen may have anti-cancer properties through a specific biological mechanism, but these findings have not been tested in humans. Much more research, including human clinical trials, would be needed before hydrogen could be considered a treatment for endometrial cancer.
Abstract (excerpt)
Background: Pyroptosis belongs to a novel inflammatory programmed cell death pathway, with the possible prognosis of endometrial cancer related to the terminal protein GSDMD. Hydrogen exerts a biphasic effect on cancer by promoting tumor cell death and protecting normal cells, which might initiate…